Markets:

Overview

News

Currencies

International

Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

24.71 +2.23 (+9.94%)

Streaming Delayed Price Updated: 10:37 AM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 Next >

BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises ↗

February 26, 2026

Via Chartmill

BioLife (BLFS) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

BioLife (BLFS) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

BioLife Solutions' CFO Sells 30,000 Shares ↗

December 11, 2025

This bioproduction tools provider for cell and gene therapy reported a notable insider sale.

Via The Motley Fool

Topics Regulatory Compliance

BioLife (BLFS) Q3 2025 Earnings Call Transcript ↗

November 09, 2025

BioLife (BLFS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Exploring BioLife Solns's Earnings Expectations ↗

May 07, 2025

Via Benzinga

Analyst Expectations For BioLife Solns's Future ↗

November 18, 2024

Via Benzinga

BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates ↗

November 06, 2025

BioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response.

Via Chartmill

Topics Earnings

BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns ↗

August 07, 2025

BioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY.

Via Chartmill

Earnings Scheduled For March 3, 2025 ↗

March 03, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Key Takeaways From BioLife Solns Analyst Ratings ↗

September 30, 2024

Via Benzinga

Recap: BioLife Solns Q4 Earnings ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling ↗

April 19, 2024

Via Benzinga

Earnings Preview For BioLife Solns ↗

February 28, 2024

Via Benzinga

BioLife Solns: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying ↗

October 24, 2023

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Top 5 Health Care Stocks That Could Blast Off This Month ↗

August 21, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Why Shares of BioLife Solutions Plummeted This Week ↗

August 11, 2023

The company saw revenue decline, year over year, in the second quarter.

Via The Motley Fool

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗

August 09, 2023

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

Via Benzinga

Why Shares of BioLife Solutions Are Slumping on Wednesday ↗

August 09, 2023

The company reported declining revenue and reduced annual guidance.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023 ↗

July 11, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.